Latest Attention-deficit hyperactivity disorder Stories
LOS ANGELES, Oct.
Subcutaneous Trigeminal Nerve Stimulation (sTNS) for the Treatment of Neuropsychiatric Disorders LOS ANGELES, Oct. 21, 2014 /PRNewswire/ - NeuroSigma(®), Inc.
TORONTO, Oct. 16, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares.
North Carolina technical assistant wins a free space makeover PHILADELPHIA, Oct.
With an estimated one in four adults or 26.2% of the population suffering from a diagnosable mental disorder in a given year, it’s time to erase the societal stigmas that have been placed on
Prakash Masand, MD, who is a former consulting professor of psychiatry and behavioral sciences at Duke University, a New York City psychiatrist, and the founder and CEO of Global Medical Education
Bio Stimulants help in the overall growth and development of Fruits & Vegetables, along with improving their yield
PHILADELPHIA, October 9, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has received further guidance from the U.S.
The utility of Bio Stimulants in the overall growth and development of Row Crops drives the Bio Stimulants market
TORONTO, Oct. 6, 2014 /PRNewswire/ - Highland Therapeutics Inc.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.